Drugs of Dependence Regulation 1993 (ACT)
Drugs of Dependence Regulation 1993 (repealed)
SL1993-14
made under the
Drugs of Dependence Act 1989
Republication No 4
Effective: 6 March 2005
Republication date: 6 March 2005
As repealed by SL2005-3 s 7
Unauthorised version prepared by ACT Parliamentary Counsel’s Office
About this republication
The republished law
This is a republication of the Drugs of Dependence Regulation 1993 (repealed), made under the Drugs of Dependence Act 1989, including any amendment made under the Legislation Act 2001, part 11.3 (Editorial changes).It also includes any commencement, amendment, repeal or expiry affecting the republished law to 6 March 2005.
The legislation history and amendment history of the republished law are set out in endnotes 3 and 4.
Kinds of republications
The Parliamentary Counsel’s Office prepares 2 kinds of republications of ACT laws (see the ACT legislation register at type="disc">
authorised republications to which the Legislation Act 2001 applies
unauthorised republications.
The status of this republication appears on the bottom of each page.
Editorial changes
The Legislation Act 2001, part 11.3 authorises the Parliamentary Counsel to make editorial amendments and other changes of a formal nature when preparing a law for republication. Editorial changes do not change the effect of the law, but have effect as if they had been made by an Act commencing on the republication date (see Legislation Act 2001, s 115 and s 117). The changes are made if the Parliamentary Counsel considers they are desirable to bring the law into line, or more closely into line, with current legislative drafting practice.
This republication does not include amendments made under part 11.3 (see endnote 1).
Uncommenced provisions and amendments
If a provision of the republished law has not commenced or is affected by an uncommenced amendment, the symbol U appears immediately before the provision heading. The text of the uncommenced provision or amendment appears only in the last endnote.
Modifications
If a provision of the republished law is affected by a current modification, the symbol M appears immediately before the provision heading. The text of the modifying provision appears in the endnotes. For the legal status of modifications, see Legislation Act 2001, section 95.
Penalties
The value of a penalty unit for an offence against this republished law at the republication date is—
(a)if the person charged is an individual—$100; or
(b)if the person charged is a corporation—$500.
Drugs of Dependence Regulation 1993 (repealed)
made under the
Drugs of Dependence Act 1989
Contents
Page
Name of regulation 2
Drugs of dependence for Act, pt 2 2
Commercial quantities 2
Traffickable quantities 2
Schedule 1Drugs of dependence–general 3
Schedule 2Prohibited substances 8
Schedule 3Drugs of dependence–manufacturing 17
Endnotes
About the endnotes 18
Abbreviation key 18
Legislation history 19
Amendment history 20
Earlier republications 20
Drugs of Dependence Regulation 1993 (repealed)
made under the
Drugs of Dependence Act 1989
Name of regulation
This regulation is the Drugs of Dependence Regulation 1993.
Drugs of dependence for Act, pt 2
For the Act, section 4, definition of drug of dependence, the substances specified in schedule 3 are prescribed.
Commercial quantities
For the Act, section 160 (1), definition of commercial quantity—
(a)the prescribed quantity of a drug of dependence specified in schedule 1, column 2 is the quantity specified in the appropriate column or columns of schedule 1 opposite the reference to that drug; and
(b)the prescribed quantity of a prohibited substance specified in schedule 2, column 2 is the quantity specified in the appropriate column or columns of schedule 2 opposite the reference to that substance.
Traffickable quantities
For the Act, section 160 (1), definition of traffickable quantity—
(a)the prescribed quantity of a drug of dependence specified in schedule 1, column 2 is the quantity specified in the appropriate column or columns of schedule 1 opposite the reference to that drug; and
(b)the prescribed quantity of a prohibited substance specified in schedule 2, column 2 is the quantity specified in the appropriate column or columns of schedule 2 opposite the reference to that substance.
Schedule 1Drugs of dependence–general
(see s 5 and s 6)
| column 1 item | column 2 drug | column 3 traffickable quantity (grams) | column 4 commercial quantity (kilograms) | |
| 1 | Acetyldihydrocodeine | 2.00 | 2.00 | |
| 2 | Acetylmethadol | 2.00 | 2.00 | |
| 3 | Acetylmorphines | 2.00 | 2.00 | |
| 4 | Alfentanil | 0.005 | 0.005 | |
| 5 | Alphacetylmethadol | 10.00 | 10.00 | |
| 6 | Alphaprodine | 25.00 | 25.00 | |
| 7 | Amphetamine | 2.00 | 2.00 | |
| 8 | Amylobarbitone, except if packed and labelled for injection | 20.00 | 20.00 | |
| 9 | Anileridine | 25.00 | 25.00 | |
| 10 | Benzylmorphine | 5.00 | 5.00 | |
| 11 | Bezitramide | 5.00 | 5.00 | |
| 12 | Buprenorphine | 0.05 | 0.05 | |
| 13 | Butobarbitone | 20.00 | 20.00 | |
| 14 | Butorphanol | 2.00 | 2.00 | |
| 15 | Carfentanyl | 0.005 | 0.005 | |
| 16 | Cocaine | 2.00 | 2.00 | |
| 17 | Codeine, except if compounded with 1 or more other medicaments— | |||
| (a) in divided preparations containing 30 mg or less of codeine per dosage unit; or | ||||
| (b) in undivided preparations containing 1% or less of codeine | 10.00 | 10.00 | ||
| 18 | Codeine-N-oxide | 10.00 | 10.00 | |
| 19 | Concentrate of poppy straw (the material arising when poppy straw has entered into a process for concentration of its alkaloids) | 250.00 | 250.00 | |
| 20 | 4-Cyano-1-methyl-4-phenylpiperidine (Pethidine intermediate A) | 10.00 | 10.00 | |
| 21 | Cyclobarbitone | 20.00 | 20.00 | |
| 22 | Dexamphetamine | 2.00 | 2.00 | |
| 23 | Dextromoramide | 2.00 | 2.00 | |
| 24 | Dextropropoxyphene, except if— | |||
| (a) in divided preparations containing 135 mg or less of dextropropoxyphene per dosage unit; or | ||||
| (b) in liquid preparations containing 2.5% or less of dextropropoxyphene | 27.00 | 27.00 | ||
| 25 | Difenoxin, except in preparations containing, per dosage unit, 0.5 mg or less of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin | 2.00 | 2.00 | |
| 26 | Dihydrocodeine, except if compounded with 1 or more other medicaments— | |||
| (a) in divided preparations containing not more than 100 mg of dihydrocodeine per dosage unit; or | ||||
| (b) in undivided preparations with a concentration of not more than 2.5% of dihydrocodeine | 10.00 | 10.00 | ||
| 27 | Dihydromorphine | 10.00 | 10.00 | |
| 28 | Diphenoxylate, except in preparations containing, per dosage unit, 2.5 mg or less of diphenoxylate and a quantity of atropine sulphate equivalent to at least 1% of the dose of diphenoxylate | 2.00 | 2.00 | |
| 29 | Dipipanone | 10.00 | 10.00 | |
| 30 | Dronabinol | 6.00 | 6.00 | |
| 31 | Drotebanol | 2.00 | 2.00 | |
| 32 | Ethylamphetamine | 2.00 | 2.00 | |
| 33 | Ethylmorphine, except if compounded with 1 or more other medicaments— | |||
| (a) in divided preparations containing not more than 100 mg of ethylmorphine per dosage unit; or | ||||
| (b) in undivided preparations with a concentration of not more than 2.5% of ethylmorphine | 2.00 | 2.00 | ||
| 34 | Fentanyl | 0.005 | 0.005 | |
| 35 | Flunitrazepam | 0.40 | 0.40 | |
| 36 | Hydrocodone | 2.00 | 2.00 | |
| 37 | Hydromorphinol | 2.00 | 2.00 | |
| 38 | Hydromorphone | 2.00 | 2.00 | |
| 39 | Levamphetamine | 2.00 | 2.00 | |
| 40 | Levomethamphetamine | 2.00 | 2.00 | |
| 41 | Levomoramide | 2.00 | 2.00 | |
| 42 | Levorphanol | 1.00 | 1.00 | |
| 43 | Methadone | 2.00 | 2.00 | |
| 44 | Methamphetamine | 2.00 | 2.00 | |
| 45 | Methyldihydromorphine | 2.00 | 2.00 | |
| 46 | Methylphenidate | 2.00 | 2.00 | |
| 47 | 1-Methyl-4-phenylpiperidine-4-carboxylic Acid (Pethidine intermediate C) | 10.00 | 10.00 | |
| 48 | Morphine | 2.00 | 1.50 | |
| 49 | Morphine Methobromide | 2.00 | 1.00 | |
| 50 | Morphine-N-oxide | 2.00 | 2.00 | |
| 51 | Nabilone | 0.40 | 0.40 | |
| 52 | Norcodeine | 2.00 | 2.00 | |
| 53 | Normethadone | 5.00 | 5.00 | |
| 54 | Opium in any form, except the alkaloids noscapine and papaverine | 20.00 | 20.00 | |
| 55 | Oxycodone | 5.00 | 5.00 | |
| 56 | Oxymorphone | 2.00 | 2.00 | |
| 57 | Pentazocine | 20.00 | 20.00 | |
| 58 | Pentobarbitone, except if packed and labelled for injection | 20.00 | 20.00 | |
| 59 | Pethidine | 10.00 | 10.00 | |
| 60 | Phendimetrazine | 5.00 | 5.00 | |
| 61 | Phenmetrazine | 5.00 | 5.00 | |
| 62 | Phenoperidine | 1.00 | 1.00 | |
| 63 | 4-Phenylpiperidine-4-carboxylic Acid Ethyl Ester (Pethidine intermediate B) | 10.00 | 10.00 | |
| 64 | Pholcodine, except if compounded with 1 or more other medicaments— | |||
| (a) in divided preparations containing not more than 100 mg of pholcodine per dosage unit; or | ||||
| (b) in undivided preparations with a concentration of not more than 2.5% of pholcodine | 5.00 | 5.00 | ||
| 65 | Piritramide | 1.00 | 1.00 | |
| 66 | Propiram | 10.00 | 10.00 | |
| 67 | Quinalbarbitone | 20.00 | 20.00 | |
| 68 | Racemoramide | 2.00 | 2.00 | |
| 69 | Remifentanil | 1.00 | 1.00 | |
| 70 | Secbutobarbitone | 20.00 | 20.00 | |
| 71 | Sufentanil | 0.005 | 0.005 | |
| 72 | Thebacon | 2.00 | 2.00 | |
| 73 | Thebaine | 2.00 | 2.00 | |
| 74 | Tilidine | 20.00 | 20.00 | |
| 75 | A substance that is, in relation to a drug of dependence specified elsewhere in this schedule— | |||
| (a) an active principle of that drug; | ||||
| (b) a preparation or admixture of that drug; or | ||||
| (c) a salt of that drug or active principle; | ||||
| except if the substance is separately specified in this schedule | The minimum traffickable quantity and the minimum commercial quantity, respectively, of— | |||
| (a) the drug of dependence in relation to which the substance is specified in this item; or | ||||
| (b) if there is more than 1 such drug—the drug mentioned in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least. | ||||
Schedule 2Prohibited substances
(see s 5 and s 6)
| column 1 item | column 2 substances | column 3 traffickable quantity (grams | column 4 commercial quantity (kilograms) |
| 1 | Acetorphine | 2.00 | 2.00 |
| 2 | Acetyl- a-methylfentanyl | 0.005 | 0.005 |
| 3 | Alkoxyamphetamines and bromo-substituted alkoxyamphetamines, except if separately specified in this schedule | 0.50 | 0.50 |
| 4 | Alkoxyphenethylamines and alkyl-substituted alkoxyphenethylamines, except if separately specified in this schedule | 0.50 | 0.50 |
| 5 | Allylprodine | 2.00 | 2.00 |
| 6 | Alphameprodine | 0.20 | 0.20 |
| 7 | Alphamethadol | 0.20 | 0.20 |
| 8 | 2-Amino-1-(2,5-dimethoxy-4-methyl) phenylpropane (STP, DOM) | 0.50 | 0.50 |
| 9 | Benzethidine | 10.00 | 10.00 |
| 10 | Betacetylmethadol | 5.00 | 5.00 |
| 11 | Betameprodine | 5.00 | 5.00 |
| 12 | Betamethadol | 5.00 | 5.00 |
| 13 | Betaprodine | 5.00 | 5.00 |
| 14 | 4-Bromo-3,5-dimethoxyamphetamine | 0.50 | 0.50 |
| 15 | 4-Bromo-2,5-dimethoxyphenethylamine (BDMPEA) | 0.50 | 0.50 |
| 16 | 3-Bromo-4-methoxyamphetamine | 0.50 | 0.50 |
| 17 | 4-Bromo-3-methoxyamphetamine | 0.50 | 0.50 |
| 18 | Bufotenine | 2.00 | 2.00 |
| 19 | Cannabis | 100.00 | 100.00 |
| 20 | Cannabis oil | 2.00 | 2.00 |
| 21 | Cannabis resin | 20.00 | 50.00 |
| 22 | Cathinone | 2.00 | 2.00 |
| 23 | Clonitazene | 5.00 | 5.00 |
| 24 | Coca leaf | 250.00 | 80.00 |
| 25 | Codoxime | 10.00 | 10.00 |
| 26 | 4-Cyano-2-dimethylamino-4,4-diphenylbutane (Methadone intermediate) | 2.00 | 2.00 |
| 27 | Desomorphine | 2.00 | 2.00 |
| 28 | Diampromide | 5.00 | 5.00 |
| 29 | Diethylthiambutene | 5.00 | 5.00 |
| 30 | N,N-Diethyltryptamine (DET) | 2.00 | 2.00 |
| 31 | Dimenoxadol | 10.00 | 10.00 |
| 32 | Dimepheptanol | 10.00 | 10.00 |
| 33 | 2,4-Dimethoxyamphetamine | 0.50 | 0.50 |
| 34 | 3,4-Dimethoxyamphetamine | 0.50 | 0.50 |
| 35 | 2,5-Dimethoxy-4-bromoamphetamine (DOB) | 0.50 | 0.50 |
| 36 | 3,4-Dimethoxy-5-ethoxyamphetamine | 0.50 | 0.50 |
| 37 | 2,5-Dimethoxy-4-ethoxyamphetamine | 0.50 | 0.50 |
| 38 | 4,5-Dimethoxy-2-ethoxyamphetamine | 0.50 | 0.50 |
| 39 | 2,5-Dimethoxy-4-ethyl- a-methylphenylethylamine (DOET) | 0.50 | 0.50 |
| 40 | 2,3-Dimethoxy-4,5-methylenedioxyamphetamine | 0.50 | 0.50 |
| 41 | 2,5-Dimethoxy-3,4-methylenedioxyamphetamine | 0.50 | 0.50 |
| 42 | 2,5-Dimethoxy - a-methylphenyleth ylamine (DMA) | 0.50 | 0.50 |
| 43 | 3,4-Dimethoxyphenylethylamine | 0.50 | 0.50 |
| 44 | 3-(2-Dimethylaminoethyl)-4-hydroxyindole (Psilocine, Psilotsin) | 2.00 | 2.00 |
| 45 | 3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (DMHP) | 2.00 | 2.00 |
| 46 | Dimethylthiambutene | 20.00 | 20.00 |
| 47 | N,N,-Dimethyltryptamine (DMT) | 2.00 | 2.00 |
| 48 | Dioxaphetyl Butyrate | 2.00 | 2.00 |
| 49 | Ecgonine | 10.00 | 10.00 |
| 50 | 4,5-Ethylenedioxy-3-methoxyamphetamine | 0.50 | 0.50 |
| 51 | Ethylmethylthiambutene | 10.00 | 10.00 |
| 52 | Eticyclidine (PCE) | 2. 00 | 2.00 |
| 53 | Etonitazene | 5.00 | 5.00 |
| 54 | Etorphine | 5.00 | 2.00 |
| 55 | Etoxeridine | 5.00 | 5.00 |
| 56 | Fenetylline | 2.00 | 2.00 |
| 57 | Furethidine | 1.00 | 1.00 |
| 58 | Harmaline | 2.00 | 2.00 |
| 59 | Harmine | 2.00 | 2.00 |
| 60 | Heroin | 2.00 | 1.50 |
| 61 | 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran (Parahexyl) | 2.00 | 2.00 |
| 62 | 4-Hydroxy-butanoic acid | 0.50 | 0.50 |
| 64 | b-Hydroxyfentanyl | 0.005 | 0.005 |
| 65 | b-Hydroxy-3-methylfentanyl | 0.005 | 0.005 |
| 66 | Hydroxypethidine | 5.00 | 5.00 |
| 67 | Isomethadone | 2.00 | 2.00 |
| 68 | Ketobemidone | 2.00 | 2.00 |
| 69 | Levomethorphn | 2.00 | 2.00 |
| 70 | Levophenacylmorphan | 2.00 | 2.00 |
| 71 | Lysergic Acid | 0.002 | 0.002 |
| 72 | Lysergide (LSD, LSD-25) | 0.002 | 0.002 |
| 73 | Mecloqualone | 60.00 | 60.00 |
| 74 | Mescaline-see 3,4,5-Trimethoxyphenethylamine | ||
| 75 | Metazocine | 7.00 | 7.00 |
| 76 | Methaqualone | 50.00 | 50.00 |
| 77 | 2-Methoxy-3, 4-methylenedioxyamphetamine | 50.00 | 50.00 |
| 78 | 2-Methoxy-4, 5-methylenedioxyamphetamine | 0.50 | 0.50 |
| 79 | 4-Methoxy-2, 3-methylenedioxyamphetamine | 0.50 | 0.50 |
| 80 | 5-Methoxy-3, 4-methylenedioxy- a-methylphenylethylamine (MMDA) | 0.50 | 0.50 |
| 81 | 2-Methoxy-3, 4-methylenedioxyphenylethylamine | 0.50 | 0.50 |
| 82 | 3-Methoxy-4, 5-methylenedioxyphenylethylamine | 0.50 | 0.50 |
| 83 | 4-Methoxy- a-methylphenylethylamine (PMA) | 0.50 | 0.50 |
| 84 | 4-Methoxyphenylethylamine | 0.50 | 0.50 |
| 85 | 4-Methylaminorex | 2.00 | 2.00 |
| 86 | Methyldesorphine | 2.00 | 2.00 |
| 87 | 3, 4-Methylenedioxyamphetamine (MDA) | 0.50 | 0.50 |
| 88 | 3, 4-Methylenedioxy-N, a-dimethylphenylethylamine (MDMA) | 0.50 | 0.50 |
| 89 | 3, 4-Methylenedioxy-N-ethylamphetamine (MDE) | 0.50 | 0.50 |
| 90 | 3-Methylfentanyl | 0.005 | 0.005 |
| 91 | a -Methylfentanyl | 0.005 | 0.005 |
| 92 | 2-Methyl-3-morpholino-1,1-diphenylpropane Carboxylic Acid (Moramide intermediate) | 8.00 | 8.00 |
| 93 | 1-Methyl-4-phenyl-4-piperidinol propionate (MPPP) | 2.00 | 2.00 |
| 94 | 3-Methylthiofentanyl | 0.005 | 0.005 |
| 95 | a-Methylthiofentanyl | 0.005 | 0.005 |
| 96 | Metopon | 2.00 | 2.00 |
| 97 | Morpheridine | 2.00 | 2.00 |
| 98 | Muscimol | 2.00 | 2.00 |
| 99 | Myrophine | 20.00 | 20.00 |
| 100 | Nicocodine | 2.00 | 2.00 |
| 101 | Nicodicodine | 2.00 | 2.00 |
| 102 | Nicomorphine | 2.00 | 2.00 |
| 103 | Noracymethadol | 2.00 | 2.00 |
| 104 | Norlevorphanol | 2.00 | 2.00 |
| 105 | Normorphine | 20.00 | 20.00 |
| 106 | Norpipanone | 10.00 | 10.00 |
| 107 | Para-fluorofentanyl | 0.005 | 0.005 |
| 108 | Phenadoxone | 10.00 | 10.00 |
| 109 | Phenampromide | 10.00 | 10.00 |
| 110 | Phenazocine | 1.00 | 1.00 |
| 111 | Phencyclidine (PCP) | 2.00 | 2.00 |
| 112 | Phenomorphan | 5.00 | 5.00 |
| 113 | 1-Phenylethyl-4-phenyl-4-piperidinol acetate (PEPAP) | 2.00 | 2.00 |
| 114 | Piminodine | 10.00 | 10.00 |
| 115 | Proheptazine | 1.00 | 1.00 |
| 116 | Properidine | 25.00 | 25.00 |
| 117 | Psilocine—see 3-(2-Dimethylaminoethyl)-4-hydroxyindole | ||
| 118 | Psilocybine | 2.00 | 2.00 |
| 119 | Psilotsin—see 3-(2-Dimethylaminoethyl)-4-hydroxyindole | ||
| 120 | Racemethorphan | 2.00 | 2.00 |
| 121 | Racemorphan | 2.00 | 2.00 |
| 122 | Rolicyclidine (PHP, PCPY) | 2.00 | 2.00 |
| 123 | Tenocyclidine (TCP) | 2.00 | 2.00 |
| 124 | Tetrahydrocannabinols (THC) and their alkyl homologues, except if separately specified in schedule 1 or this schedule | 2.00 | 5.00 |
| 125 | 2, 3, 4, 5-Tetramethoxyamphetamine | 0.50 | 0.50 |
| 126 | Thiofentanyl | 0.005 | 0.005 |
| 127 | Trimeperidine | 10.00 | 10.00 |
| 128 | 2, 3, 4-Trimethoxyamphetamine | 0.50 | 0.50 |
| 129 | 2, 3, 5-Trimethoxyamphetamine | 0.50 | 0.50 |
| 130 | 2, 3, 6-Trimethoxyamphetamine | 0.50 | 0.50 |
| 131 | 2, 4, 5-Trimethoxyamphetamine | 0.50 | 0.50 |
| 132 | 2, 4, 6-Trimethoxyamphetamine | 0.50 | 0.50 |
| 133 | 3, 4, 5-Trimethoxy- a-methylphenylethylamine (TMA) | 0.50 | 0.50 |
| 134 | 3, 4, 5-Trimethoxyphenethylamine (mescaline) and other substances structurally derived from methoxy-phenylethylamine, except— | ||
| (a) methoxyphenamine; or | |||
| (b) if separately specified in this schedule | 7.50 | 7.50 | |
| 135 | 1-(3, 4, 5-Trimethoxyphenyl)-2-aminobutane | 0.50 | 0.50 |
| 136 | 2, 4, 5-Trimethoxyphenylethylamine | 0.50 | 0.50 |
| 137 | A substance that is, in relation to a prohibited substance specified elsewhere in this schedule— | ||
| (a) an active principle of that prohibited substance; | |||
| (b) a preparation or admixture of that prohibited substance; or | |||
| (c) a salt of that prohibited substance or active principle; | |||
| except if the firstmentioned substance is separately specified in this schedule | The minimum traffickable quantity and the minimum commercial quantity, respectively, of— | ||
| (a) the prohibited substance in relation to which the substance is specified in this item; or | |||
| (b) if there is more than 1 such prohibited substance—the prohibited substance mentioned in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least. | |||
| 138 | A substance (drug analogue) that is, in relation to another substance (being a drug of dependence or a substance specified elsewhere in this schedule, or a stereoisomer, a structural isomer (with the same constituent groups) or an alkaloid of such a drug or substance)— | ||
| (a) a stereoisomer; or | |||
| (b) a structural isomer having the same constituent groups; or | |||
| (c) an alkaloid; or | |||
| (d) a structural modification notionally obtained in 1 or more of the following ways: | |||
| (i) by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures; | |||
| (ii) by the addition of hydrogen atoms to 1 or more unsaturated bonds; | |||
| (iii) by the addition of 1 or more of the following groups, namely alkoxy, cyclic diether, acyl, acyloxy, mono-amino and dialkylamino groups with up to 6 carbon atoms in any alkyl residue; alkyl, alkenyl and alkynyl groups with up to 6 carbon atoms in the group, if the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon; and halogen, hydroxy, nitro and amino groups; | |||
| (iv) by the replacement of 1 or more of the groups specified in subparagraph (iii) with another such group or groups; | |||
| (v) by the conversion of a carboxyl or an ester group into an amide group; or | |||
| (e) otherwise an homologue, analogue, chemical derivative or substance substantially similar in chemical structure; | |||
| however manufactured or actually obtained, except if the drug analogue— | |||
| (f) is a drug of dependence; or | |||
| (g) is separately specified in this schedule; or | |||
| (h) is specified in a schedule to the Poisons and Drugs Act 1978; or | |||
| (i) is specified in the Public Health (Prohibited Drugs) Act 1957, schedule 1 | The minimum traffickable quantity and the minimum commercial quantity, respectively, of— | ||
| (a) the drug of dependence or prohibited substance in relation to which the substance is a drug analogue; or | |||
| (b) if there is more than 1 such drug or prohibited substance—the drug or prohibited substance mentioned in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least. | |||
Schedule 3Drugs of dependence–manufacturing
(see s 4)
Table 1
| column 1 item | column 2 substance |
| 1 | Acetylmorphines |
| 2 | Amphetamine |
| 3 | Amylobarbitone |
| 4 | Buprenorphine |
| 5 | Butobarbitone |
| 6 | Butorphanol |
| 7 | Carfentanyl |
| 8 | Cyclobarbitone |
| 9 | Dexamphetamine |
| 10 | Dronabinol |
| 11 | Ethylamphetamine |
| 12 | Flunitrazepam |
| 13 | Levamphetamine |
| 14 | Levomethamphetamine |
| 15 | Methamphetamine |
| 16 | Methylphenidate |
| 17 | Nabilone |
| 18 | Pentazocine |
| 19 | Pentobarbitone |
| 20 | Phendimetrazine |
| 21 | Phenmetrazine |
| 22 | Quinalbarbitone |
| 23 | Remifentanil |
| 24 | Secbutobarbitone |
| 25 | A substance that is, in relation to a drug of dependence specified elsewhere in this schedule— |
| (a) an active principle of that drug; or | |
| (b) a preparation or admixture of that drug; or | |
| (c) a salt of that drug or active principle. |
Endnotes
About the endnotes
Amending and modifying laws are annotated in the legislation history and the amendment history. Current modifications are not included in the republished law but are set out in the endnotes.
Not all editorial amendments made under the Legislation Act, part 11.3 are annotated in the amendment history. Full details of any amendments can be obtained from the Parliamentary Counsel’s Office.
Uncommenced amending laws and expiries are listed in the legislation history and the amendment history. These details are underlined. Uncommenced provisions and amendments are not included in the republished law but are set out in the last endnote.
If all the provisions of the law have been renumbered, a table of renumbered provisions gives details of previous and current numbering.
The endnotes also include a table of earlier republications.
Abbreviation key
am = amended ord = ordinance amdt = amendment orig = original ch = chapter par = paragraph/subparagraph def = definition pres = present dict = dictionary prev = previous disallowed = disallowed by the Legislative (prev...) = previously Assembly pt = part div = division r = rule/subrule exp = expires/expired renum = renumbered Gaz = gazette reloc = relocated hdg = heading R[X] = Republication No IA = Interpretation Act 1967 RI = reissue ins = inserted/added s = section/subsection LA = Legislation Act 2001 sch = schedule LR = legislation register sdiv = subdivision LRA = Legislation (Republication) Act 1996 sub = substituted mod = modified/modification SL = Subordinate Law o = order underlining = whole or part not commenced om = omitted/repealed or to be expired
Legislation history
This regulation was originally the Drugs of Dependence Regulations. It was renamed under the Legislation Act 2001.
Drugs of Dependence Regulation SL 1993 No 14
notified 31 March 1993
regs 1-3 commenced 31 March 1993
remainder commenced 31 March 1993 (s 2 (2) and Gaz 1993 No S53)as amended by
Drugs of Dependence Regulations (Amendment) SL 1995 No 29
notified 2 August 1995
commenced 2 August 1995Drugs of Dependence Regulations (Amendment) SL 1996 No 26
notified 1 November 1996
commenced 1 November 1996Drugs of Dependence Regulations (Amendment) SL 1998 No 20
notified 17 June 1998
s 3 (part) commenced 19 June 1998 (s 1 (2))
remainder 17 June 1998 (s 1 (1))Legislation (Consequential Amendments) Act 2001 No 44 pt 114
notified 26 July 2001 (Gaz 2001 No 30)
s 1, s 2 commenced 26 July 2001 (IA s 10B)
pt 114 commenced 12 September 2001 (s 2 and see Gaz 2001 No S65)as repealed by
Drugs of Dependence Regulation 2005 SL2005-3 s 7
notified LR 4 March 2005
s 1, s 2 commenced 4 March 2005 (LA s 75 (1))
s 7 commenced 6 March 2005 (s 2 and see Criminal Code (Serious Drug Offences) Amendment Act 2004 A2004-56 s 2 and LA s 79)Amendment history
Name of regulation
s 1am R2 LA; R3 LA
Commencement
s 2om 2001 No 44 amdt 1.1224
Interpretation
s 3om 2001 No 44 amdt 1.1224
Drugs of dependence—general
sch 1am 1995 No 29
sub 1998 No 20
Prohibited substances
sch 2am 1995 No 29; 1996 No 26
sub 1998 No 20
Drugs of dependence—manufacturing
sch 3sub 1998 No 20
Earlier republications
Some earlier republications were not numbered. The number in column 1 refers to the publication order.
Since 12 September 2001 every authorised republication has been published in electronic pdf format on the ACT legislation register. A selection of authorised republications have also been published in printed format. These republications are marked with an asterisk (*) in column 1. Except for the footer, electronic and printed versions of an authorised republication are identical.
Republication No
Amendments to
Republication date
1 Act 1998 No 20 31 January 1998 2 A2001-44 12 September 2001 3 A2001-44 2 November 2004
© Australian Capital Territory 2005
0
0
0